EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain

Dario Cocito, Erdita Peci, Palma Ciaramitaro, Aristide Merola, Leonardo Lopiano

Pain Research and Treatment · 20.05.2014 · 2014 · 1-4

DOI: 10.1155/2014/854560 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pain Research and Treatment, erschienen am 20.05.2014. Verfasst von Dario Cocito und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, AOU Città della Salute e della Scienza di Torino, University of Turin, Via Cherasco 15, 10124 Torino, Italy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Associazione Neuropatie Croniche Piemonte ONLUS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This study evaluates the efficacy of palmitoylethanolamide ultramicronized (PEA-um) as an add-on treatment in patients with diabetic or traumatic neuropathic pain (NP).

Methods

30 patients with chronic NP were assessed with Visual Analogue Scale (VAS), NP Symptom Inventory (NPSI), and Health Questionnaire Five Dimensions (EQ-5D), both at baseline and after 10 and 40 days of treatment with 1200 mg/die of PEA-um. All other therapies were maintained stable during the follow-up period.

Results

VAS mean score significantly improved within the first 10 days, ranging from 8.20 ± 1.53 to 6.40 ± 1.83 ( P < 0.002 ), with a further decrease to 5.80 ± 2.04 ( P < 0.001 ) after 40 days of PEA-um administration. Moreover, NPSI total score improved from 5.2 ± 1.5 to 3.8 ± 2.1 ( P : 0.025) and EQ-5D ranged from −0.30 ± 0.65 to 0.5 ± 0.34 ( P < 0.001 ) between T0 and T2.

Conclusions

This study reports the prospective short-term efficacy data of oral PEA-um in patients with diabetic or traumatic NP. A significant improvement was observed both in VAS and NPSI scores and in quality of life scales after 40 days of treatment, although some limitations should be considered, including the short followup and the open-label study design.

Autor:innen und Institutionen

  • Department of Neuroscience, AOU Città della Salute e della Scienza di Torino, University of Turin, Via Cherasco 15, 10124 Torino, Italy.

Förderung

  • Associazione Neuropatie Croniche Piemonte ONLUS

Zitieren

APA

Cocito, D., Peci, E., Ciaramitaro, P., Merola, A., & Lopiano, L. (2014). Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain. Pain Research and Treatment, 2014, 1-4. https://doi.org/10.1155/2014/854560

Vancouver

Cocito D, Peci E, Ciaramitaro P, Merola A, Lopiano L. Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain. Pain Research and Treatment. 2014;2014:1-4. doi:10.1155/2014/854560

BibTeX
@article{Cocito2014,
  author = {Cocito, Dario and Peci, Erdita and Ciaramitaro, Palma and Merola, Aristide and Lopiano, Leonardo},
  title = {Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain},
  journal = {Pain Research and Treatment},
  year = {2014},
  volume = {2014},
  pages = {1--4},
  doi = {10.1155/2014/854560}
}
Kostenlos starten →